OSIRIS THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout WILMINGTON, Del., March 14, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you own shares of Osiris Therapeutics, Inc. (NASDAQ GM: OSIR)? Did you purchase any of your shares prior to March...

EQUITY NOTICE: Rosen Law Firm Reminds Osiris Therapeutics, Inc. Investors of Important January 22, 2016 Deadline in Class Action Filed by Firm – OSIR NEW YORK, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Osiris Therapeutics, Inc. (NASDAQ:OSIR) securities from May 12, 2014 through...

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Osiris Therapeutics, Inc. -- OSIR NEW YORK, Dec. 22, 2015 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Osiris Therapeutics, Inc....

Mesoblast Unveils Path to Bring Its Key Products to Market NEW YORK and MELBOURNE, Australia, Aug. 25, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today reported 2014 financial results and unveiled its...